1. Home
  2. ALMS vs XPER Comparison

ALMS vs XPER Comparison

Compare ALMS & XPER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • XPER
  • Stock Information
  • Founded
  • ALMS 2021
  • XPER 1990
  • Country
  • ALMS United States
  • XPER United States
  • Employees
  • ALMS N/A
  • XPER N/A
  • Industry
  • ALMS
  • XPER Semiconductors
  • Sector
  • ALMS
  • XPER Technology
  • Exchange
  • ALMS NYSE
  • XPER Nasdaq
  • Market Cap
  • ALMS 402.6M
  • XPER 370.5M
  • IPO Year
  • ALMS 2024
  • XPER 2003
  • Fundamental
  • Price
  • ALMS $4.13
  • XPER $5.82
  • Analyst Decision
  • ALMS Strong Buy
  • XPER Strong Buy
  • Analyst Count
  • ALMS 6
  • XPER 3
  • Target Price
  • ALMS $19.80
  • XPER $13.00
  • AVG Volume (30 Days)
  • ALMS 686.1K
  • XPER 364.4K
  • Earning Date
  • ALMS 08-12-2025
  • XPER 08-06-2025
  • Dividend Yield
  • ALMS N/A
  • XPER N/A
  • EPS Growth
  • ALMS N/A
  • XPER N/A
  • EPS
  • ALMS N/A
  • XPER N/A
  • Revenue
  • ALMS $17,389,000.00
  • XPER $488,877,000.00
  • Revenue This Year
  • ALMS N/A
  • XPER $0.50
  • Revenue Next Year
  • ALMS N/A
  • XPER $8.71
  • P/E Ratio
  • ALMS N/A
  • XPER N/A
  • Revenue Growth
  • ALMS N/A
  • XPER N/A
  • 52 Week Low
  • ALMS $2.76
  • XPER $5.73
  • 52 Week High
  • ALMS $13.11
  • XPER $11.08
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • XPER 16.26
  • Support Level
  • ALMS N/A
  • XPER $7.56
  • Resistance Level
  • ALMS N/A
  • XPER $7.59
  • Average True Range (ATR)
  • ALMS 0.00
  • XPER 0.25
  • MACD
  • ALMS 0.00
  • XPER -0.20
  • Stochastic Oscillator
  • ALMS 0.00
  • XPER 4.22

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About XPER Xperi Inc.

Xperi Inc is a consumer and entertainment technology company. Its offering comprises a portfolio of software and services. The company creates extraordinary experiences at home and on the go for millions of consumers around the world, enabling audiences to connect with content in a more intelligent, immersive, and personal way. Its business is divided into four categories based on the products delivered and customers served: Pay-TV, Consumer Electronics, Connected Car, and Platform Solutions. It generates the majority of its revenue from the Consumer Electronics segment. Its also have sales in Japan, Europe and Middle East, China, South Korea, Latin America, and Others.

Share on Social Networks: